Sawai Launches Vardenafil Tablets

Jun. 23. 2020

Osaka, Japan - March 23, 2020 - Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Kenzo Sawai) announced the launch dates with the below mentioned schedule for Vardenafil tablets (the branded product: LEVITRA®).

Vardenafil tablets are prescribed for the treatment of erectile dysfunction.

Product Name Launch Date
VARDENAFIL Tablets 10 mg [SAWAI] July 6, 2020
VARDENAFIL Tablets 20 mg [SAWAI]

The products announced in this press release are not approved by the Food & Drug Administration for sale and distribution in the United States.